Value creation or value trap?

Print this page
Email Icon

Email to a colleague

View or print Value creation or value trap? Value creation or value trap?

Adobe PDF Format

The value potential of opportunities in the pharmaceuticals and life sciences sector can be significant. But so can the risks. Understanding whether an opportunity has value can be challenging. Our team of dedicated specialists help companies and investors create, preserve and measure value. Our clients operate or invest in a broad spectrum of pharmaceuticals and life sciences related sectors, including:

pharmaceuticals
biotechnology
over the counter (OTC) products
generics
medical devices
diagnostics
animal health
nutraceuticals
contract research
contract manufacturing
drug delivery

Publications Search Page

Search Publications

Contacts

Jo Pisani
+44 (0) 20 7804 3744

Related Services

Economics

Find out more

Bookmark with:

© 2010 PricewaterhouseCoopers. All rights reserved. "PricewaterhouseCoopers" and "PwC" refer to the network of member firms of PricewaterhouseCoopers International Limited (PwCIL). Each member firm is a separate legal entity and does not act as agent of PwCIL or any other member firm. PwCIL does not provide any services to clients. PwCIL is not responsible or liable for the acts or omissions of any of its member firms nor can it control the exercise of their professional judgment or bind them in any way. No member firm is responsible or liable for the acts or omissions of any other member firm nor can it control the exercise of another member firm's professional judgment or bind another member firm or PwCIL in any way.